SWI/SNF proteins as targets in cancer therapy

Santiago Schiaffino-Ortega1, Carlos Balinas2, Marta Cuadros3,4

  • 1GENyO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, Granada, Spain. santiago.schiaffino@genyo.es.

Insights

Synthetic lethal interactions involving SWI/SNF complex proteins offer new cancer treatment strategies. This research highlights potential therapeutic avenues by targeting these specific interactions for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The SWI/SNF complex is crucial for chromatin remodeling and gene regulation.
  • Dysregulation of SWI/SNF components is implicated in various cancers.
  • Understanding SWI/SNF complex functions is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To explore synthetic lethal interactions involving SWI/SNF complex proteins.
  • To identify potential therapeutic targets within the SWI/SNF pathway for cancer treatment.
  • To evaluate the feasibility of targeting these interactions for novel cancer therapies.

Main Methods:

  • Review of recent literature on SWI/SNF complex and synthetic lethality.
  • Analysis of identified synthetic lethal interactions.
  • Discussion of potential therapeutic strategies based on these interactions.

Main Results:

  • Several synthetic lethal interactions involving SWI/SNF complex proteins have been identified.
  • These interactions present opportunities for targeted cancer therapy.
  • The findings suggest a new direction for developing precision oncology treatments.

Conclusions:

  • Synthetic lethality involving SWI/SNF proteins provides a promising basis for new cancer therapeutics.
  • Targeting these interactions could lead to effective and specific cancer treatments.
  • Further research into these interactions may unlock novel therapeutic approaches.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K